Regulation of A Disintegrin And Metalloprotease-33 Expression by Transforming Growth Factor-β
- 1 May 2012
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 46 (5) , 633-640
Abstract
The asthma susceptibility gene, a disintegrin and metalloprotease-33 (ADAM33), is selectively expressed in mesenchymal cells, and the activity of soluble ADAM33 has been linked to angiogenesis and airway remodeling. Transforming growth factor (TGF)-β is a profibrogenic growth factor, the expression of which is increased in asthma, and recent studies show that it enhances shedding of soluble ADAM33. In this study, we hypothesized that TGF-β also affects ADAM33 expression in bronchial fibroblasts in asthma. Primary fibroblasts were grown from bronchial biopsies from donors with and those without asthma, and treated with TGF-β2 to induce myofibroblast differentiation. ADAM33 expression was assessed using quantitative RT-PCR and Western blotting. To examine the mechanisms whereby TGF-β2 affected ADAM33 expression, quantitative methylation-sensitive PCR, chromatin immunoprecipitation, and nuclear accessibility assays were conducted on the ADAM33 promoter. We found that TGF-β2 caused a time- and concentration-dependent reduction in ADAM33 mRNA expression in normal and asthmatic fibroblasts, affecting levels of splice variants similarly. TGF-β2 also induced ADAM33 protein turnover and appearance of a cell-associated C-terminal fragment. TGF-β2 down-regulated ADAM33 mRNA expression by causing chromatin condensation around the ADAM33 promoter with deacetylation of histone H3, demethylation of H3 on lysine-4, and hypermethylation of H3 on lysine-9. However, the methylation status of the ADAM33 promoter did not change. Together, these data suggest that TGF-β2 suppresses expression of ADAM33 mRNA in normal or asthmatic fibroblasts. This occurs by altering chromatin structure, rather than by gene silencing through DNA methylation as in epithelial cells. This may provide a mechanism for fine regulation of levels of ADAM33 expression in fibroblasts, and may self-limit TGF-β2–induced ectodomain shedding of ADAM33.Keywords
This publication has 55 references indexed in Scilit:
- Unifying Candidate Gene and GWAS Approaches in AsthmaPLOS ONE, 2010
- Asthma susceptible genes in Chinese population: A meta-analysisRespiratory Research, 2010
- Adamalysins in biology and diseaseThe Journal of Pathology, 2009
- Sp1 Phosphorylation and Its Regulation of Gene TranscriptionMolecular and Cellular Biology, 2009
- Expression of ADAMs (“a disintegrin and metalloprotease”) in the human lungVirchows Archiv, 2009
- A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiologyThorax, 2007
- Chromatin at the crossroads. Meeting on Signalling to Chromatin EpigeneticsEMBO Reports, 2006
- Crystal structure of human histone lysine-specific demethylase 1 (LSD1)Proceedings of the National Academy of Sciences, 2006
- Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthmaClinical & Experimental Allergy, 2004
- Association of the ADAM33 gene with asthma and bronchial hyperresponsivenessNature, 2002